Design of a Novel Integration-deficient Lentivector Technology That Incorporates Genetic and Posttranslational Elements to Target Human Dendritic CellsSemih U. Tareen, Scott H. Robbins, Lisa Nelson et al.|Molecular Therapy|2013Cited by 32
Abstract 702: DCVex(TM): A novel integration-deficient lentivector technology that incorporates genetic and post-translational elements to target dendritic cellsSemih U. Tareen, Peter Berglund, Brenna Kelley-Clarke et al.|Cancer Research|2014Cited by 0